PTP1B expression contributes to gastric cancer progression

Medical Oncology

Volumn 29, Issue 2, 2012, Pages 948-956

  Wang, Jinguo ^a   Liu, Bingya ^b   Chen, Xuehua ^b   Su, Liping ^b   Wu, Pei ^a   Wu, Jian ^a   Zhu, Zhenggang ^b  

^a Yijishan Hospital   (China)

^b SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

Author keywords

Akt; Extracellular signalregulated kinase (Erk1 2); Focal adhesion kinase (FAK); Gastric cancer; Protein tyrosine phosphatase 1B (PTP1B); Src; Tumorigenesis

Indexed keywords

FOCAL ADHESION KINASE; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN KINASE B; PROTEIN KINASE P60; PROTEIN TYROSINE PHOSPHATASE 1B; FOCAL ADHESION KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN TYROSINE KINASE; SMALL INTERFERING RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL; CANCER GROWTH; CANCER STAGING; CANCER TISSUE; CARCINOGENICITY; CELL ASSAY; CELL PROLIFERATION; COLONY FORMATION; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME PHOSPHORYLATION; GENE OVEREXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; MAJOR CLINICAL STUDY; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; STOMACH CANCER; WESTERN BLOTTING; ANIMAL; BAGG ALBINO MOUSE; CLONOGENIC ASSAY; DISEASE COURSE; DRUG ANTAGONISM; ENZYME IMMUNOASSAY; FEMALE; FOLLOW UP; GENETICS; LYMPH NODE METASTASIS; MALE; METABOLISM; NUDE MOUSE; PATHOLOGY; PHOSPHORYLATION; PROGNOSIS; SIGNAL TRANSDUCTION; STOMACH; STOMACH TUMOR; SURVIVAL RATE; TUMOR CELL LINE;

ANIMALS; BLOTTING, WESTERN; CELL LINE, TUMOR; CELL PROLIFERATION; COLONY-FORMING UNITS ASSAY; DISEASE PROGRESSION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMALE; FOCAL ADHESION KINASE 1; FOLLOW-UP STUDIES; HUMANS; IMMUNOENZYME TECHNIQUES; LYMPHATIC METASTASIS; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM STAGING; PHOSPHORYLATION; PROGNOSIS; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 1; PROTO-ONCOGENE PROTEINS C-AKT; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; SRC-FAMILY KINASES; STOMACH; STOMACH NEOPLASMS; SURVIVAL RATE;

EID: 84866300400     PISSN: 13570560     EISSN: 1559131X     Source Type: Journal    
DOI: 10.1007/s12032-011-9911-2     Document Type: Article

References (31)

1. Motiwala T, Jacob ST. Role of protein tyrosine phosphatases in cancer. Prog Nucleic Acid Res Mol Biol. 2006;81:297-329.
2. Tonks NK, Diltz CD, Fischer EH. Purification of the major protein-tyrosine-phosphatases of human placenta. J Biol Chem. 1988;263:6722-30.
3. Buffart TE, et al. High resolution analysis of DNA copy-number aberrations of chromosomes 8, 13, and 20 in gastric cancers. Virchows Arch. 2009;455:213-23.
4. Scotto L, et al. Identification of copy number gain and overexpressed genes on chromosome arm 20q by an integrative genomic approach in cervical cancer: potential role in progression. Genes Chromosomes Cancer. 2008;47:755-65.
5. Warabi M, Nemoto T, Ohashi K, Kitagawa M, Hirokawa K. Expression of protein tyrosine phosphatases and its significance in esophageal cancer. Exp Mol Pathol. 2000;68:187-95.
6. Brown-Shimer S, Johnson KA, Hill DE, Bruskin AM. Effect of protein tyrosine phosphatase 1B expression on transformation by the human neu oncogene. Cancer Res. 1992;52:478-82.
7. Zhai YF, et al. Increased expression of specific protein tyrosine phosphatases in human breast epithelial cells neoplastically transformed by the neu oncogene. Cancer Res. 1993;53:2272-8.
8. Wiener JR, et al. Overexpression of the tyrosine phosphatase PTP1B is associated with human ovarian carcinomas. Am J Obstet Gynecol. 1994;170:1177-83.
9. Zhu S, Bjorge JD, Fujita DJ. PTP1B contributes to the oncogenic properties of colon cancer cells through Src activation. Cancer Res. 2007;67:10129-37.
10. Julien SG, et al. Protein tyrosine phosphatase 1B deficiency or inhibition delays ErbB2-induced mammary tumorigenesis and protects from lung metastasis. Nat Genet. 2007;39:338-46.
11. Dubé N, et al. Genetic ablation of protein tyrosine phosphatase 1B accelerates lymphomagenesis of p-53-null mice through the regulation of B-cell development. Cancer Res. 2005;65: 10088-95.
12. Alberts SR, Cervantes A, van de Velde CJ. Gastric cancer: epidemiology, pathology and treatment. Ann Oncol. 2003;14:ii31-6.
13. Roder DM. The epidemiology of gastric cancer. Gastric Cancer. 2002;5:5-11.
14. Boyle P, Levin B. World Cancer Report (2008) from the World Health Organization, worldwide cancer burden. Published by International Agency for Research on Cancer 2008.
15. Wang YW, et al. In vitro and in vivo evidence of metallopanstimulin- 1 in gastric cancer progression and tumorigenicity. Clin Cancer Res. 2006;12:4965-73.
16. Jiang Y, et al. A high expression level of insulin-like growth factor I receptor is associated with increased expression of transcription factor Sp1 and regional lymph node metastasis of human gastric cancer. Clin Exp Metastasis. 2004;21:755-64.
17. Wang J, Chen X, Liu B, Zhu Z. Suppression of PTP1B in gastric cancer cells in vitro induces a change in the genome-wide expression profile, and inhibits gastric cancer cell growth. Cell Biol Int. 2010;34:747-53.
18. Tu SP, et al. Suppression of survival expression inhibits in vivo tumorigenicity and angiogenesis in gastric cancer. Cancer Res. 2003;63:7724-32.
19. Arias-Romero LE, et al. Activation of Src by protein tyrosine phosphatase 1B is required for ErbB2 transformation of human breast epithelial cells. Cancer Res. 2009;69:4582-8.
20. Yang SH, et al. Gene copy number change events at chromosome 20 and their association with recurrence in gastric cancer patients. Clin Cancer Res. 2005;11:612-20.
21. Dubé N, Cheng A, Tremblay ML. The role of protein tyrosine phosphatase 1B in Ras signaling. Proc Natl Acad Sci USA. 2004;101:1834-9.
22. Liu SQ, Yu JP, Yu HG, Lv P, Chen HI. Activation of Akt and ERK signaling pathways induced by etoposide confer chemoresistance in gastric cancer cells. Dig Liver Dis. 2006;38:310-8.
23. Bjorge JD, Pang A, Fujita DJ. Identification of protein-tyrosine phosphatase 1B as the major tyrosine phosphatase activity capable of dephosphorylating and activating c-Src in several human breast cancer cell lines. J Biol Chem. 2000;275:41439-46.
24. Stuible M, Doody KM, Tremblay ML. PTP1B and TC-PTP: regulators of transformation and tumorigenesis. Cancer Metastasis Rev. 2008;27:215-30.
25. Liang FB, Lee SY, Liang J, Lawrence DS, Zhang ZY. The role of protein-tyrosine phosphatase 1B in integrin signaling. J Biol Chem. 2005;280:24857-63.
26. Arregui CO, Balsamo J, Lilien J. Impaired integrin mediated adhesion and signaling in fibroblasts expressing a dominantnegative mutant PTP1B. J Cell Biol. 1998;143:861-73.
27. Cheng A, Bal GS, Kennedy BP, Tremblay ML. Attenuation of adhesion-dependent signaling and cell spreading in transformed fibroblasts lacking protein tyrosine phosphatase-1B. J Biol Chem. 2001;276:25848-55.
28. Summy JM, Gallick GE. Src family kinases in tumor progression and metastasis. Cancer Metastasis Rev. 2003;22:337-58.
29. Sachdev S, Bu Y, Gelman IH. Paxillin-Y118 phosphorylation contributes to the control of Src-induced anchorage-independent growth by FAK and adhesion. BMC Cancer. 2009;9:12.
30. Zhang ZY, Lee SY. PTP1B inhibitors as potential therapeutics in the treatment of type 2 diabetes and obesity. Expert Opin Investig Drugs. 2003;12:223-33.
31. Zhang S, Zhang ZY. PTP1B as a drug target: recent developments in PTP1B inhibitor discovery. Drug Discov Today. 2007;12:373-81.